Apoptotic Protease Activating Factor 1 Protein
Introduction
Apoptotic Protease Activating Factor 1 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
<div class="infobox infobox-protein"> [@refa]
<div class="infobox-header">Apoptotic Protease Activating Factor 1 Protein</div> [@refb]
<div class="infobox-content"> [@refc]
<table> [@refd]
<tr><th>Protein Name</th><td>Apoptotic Protease Activating Factor 1</td></tr> [@refe]
<tr><th>Gene Symbol</th><td>[APAF1](/genes/apaf1)</td></tr> [@reff]
<tr><th>UniProt ID</th><td><a href="https://www.uniprot.org/uniprot/O14727" target="_blank">O14727</a></td></tr> [@refg]
<tr><th>Molecular Weight</th><td>~140 kDa</td></tr>
<tr><th>Subcellular Localization</th><td>Cytoplasm</td></tr>
<tr><th>Protein Family</th><td>Apoptotic protease-activating factor</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/inflammation" style="color:#ef9a9a">Inflammation</a>, <a href="/wiki/melanoma" style="color:#ef9a9a">Melanoma</a>, <a href="/wiki/neurodegenerative_diseases" style="color:#ef9a9a">neurodegenerative_diseases</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">30 edges</a></td>
</tr>
</table>
</div>
</div>
Overview
...
Apoptotic Protease Activating Factor 1 Protein
Introduction
Apoptotic Protease Activating Factor 1 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
<div class="infobox infobox-protein"> [@refa]
<div class="infobox-header">Apoptotic Protease Activating Factor 1 Protein</div> [@refb]
<div class="infobox-content"> [@refc]
<table> [@refd]
<tr><th>Protein Name</th><td>Apoptotic Protease Activating Factor 1</td></tr> [@refe]
<tr><th>Gene Symbol</th><td>[APAF1](/genes/apaf1)</td></tr> [@reff]
<tr><th>UniProt ID</th><td><a href="https://www.uniprot.org/uniprot/O14727" target="_blank">O14727</a></td></tr> [@refg]
<tr><th>Molecular Weight</th><td>~140 kDa</td></tr>
<tr><th>Subcellular Localization</th><td>Cytoplasm</td></tr>
<tr><th>Protein Family</th><td>Apoptotic protease-activating factor</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/inflammation" style="color:#ef9a9a">Inflammation</a>, <a href="/wiki/melanoma" style="color:#ef9a9a">Melanoma</a>, <a href="/wiki/neurodegenerative_diseases" style="color:#ef9a9a">neurodegenerative_diseases</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">30 edges</a></td>
</tr>
</table>
</div>
</div>
Overview
Apoptotic Protease Activating Factor 1 (APAF1) is the central scaffold protein of the apoptosome, a heptameric complex that serves as the activation platform for caspase-9 in the intrinsic (mitochondrial) [apoptosis](/entities/apoptosis) pathway. APAF1 plays a critical role in translating cellular stress signals into apoptotic cell death by integrating cytochrome c release from damaged mitochondria with caspase activation. The protein contains an N-terminal caspase recruitment domain (CARD), an ATPase domain, and a C-terminal WD40 repeat domain that binds cytochrome c. Upon cytochrome c release, APAF1 undergoes conformational changes, binds dATP/ATP, and oligomerizes into the apoptosome. This complex recruits and activates procaspase-9, initiating the caspase cascade that leads to orderly cell disassembly. APAF1 is essential for embryonic development, and its dysregulation is implicated in cancer (where anti-apoptotic mechanisms inhibit its function) and neurodegenerative diseases (where excessive apoptosis contributes to neuronal loss).
Structure
APAF1 is a 1248-amino acid protein with a modular domain architecture:
- N-terminal CARD domain (residues 1-100): Caspase recruitment domain that binds to procaspase-9
- ATPase domain (residues 130-400): Walker A/B motifs for nucleotide binding; undergoes conformational changes upon dATP/ATP binding
- Linker region (residues 400-500): Flexible connector between ATPase and WD40 domains
- WD40 repeat domain (residues 500-1248): 12 WD40 repeats forming a beta-propeller structure that recognizes cytochrome c
The WD40 domain is critical for cytochrome c binding and APAF1 oligomerization, which is essential for apoptosome formation.
Normal Function
APAF1 is the central scaffold of the apoptosome, a ~700 kDa heptameric complex that activates caspase-9 in response to mitochondrial apoptosis signals.
Apoptosome Assembly:
Cytochrome c release from mitochondria triggers APAF1 conformational change
dATP/ATP binding exposes the WD40 domain for cytochrome c interaction
Cytochrome c-APAF1 complexes oligomerize into the apoptosome
Procaspase-9 is recruited via CARD-CARD interactions
Autocatalytic cleavage generates active caspase-9Neuronal Role:
In [neurons](/entities/neurons), APAF1-mediated apoptosis is tightly regulated during development and in response to pathological insults. Dysregulation contributes to both excessive neuronal death (as in neurodegenerative diseases) and insufficient elimination of damaged cells (as in cancer).
Role in Disease
Neurodegeneration: Elevated APAF1 expression and apoptosome formation are observed in:
- [Alzheimer's disease](/diseases/alzheimers-disease): Neuronal loss correlates with APAF1 activation
- [Parkinson's disease](/diseases/parkinsons-disease): Mitochondrial dysfunction triggers APAF1-dependent apoptosis
- Stroke: Ischemic injury activates the intrinsic apoptosis pathway
Cancer: APAF1 acts as a tumor suppressor:
- Frequently downregulated in melanomas, lung cancers, and glioblastomas
- Somatic mutations identified in various cancers
- Restoring APAF1 sensitizes resistant tumors to chemotherapy
Therapeutic Targeting
Current therapeutic approaches targeting the APAF1-apoptosome pathway:
- Small molecule apoptosome inhibitors: Under development for neuroprotection
- Caspase-9 inhibitors: Could block downstream effects of APAF1 activation
- BCL-2 mimetics: Prevent cytochrome c release, upstream of APAF1
Research continues on developing neuroprotective strategies that modulate APAF1 activity without compromising essential apoptosis.
Key Publications
[Zou et al., APAF1 forms apoptosome with cytochrome c and caspase-9 (1999)](https://doi.org/10.1016/S0092-8674(00)80584-X)
[Acehan et al., Crystal structure of apoptosome (2002)](https://doi.org/10.1016/S1097-2765(02)00421-8)See Also
[APAF1 Gene](/genes/apaf1), [Apoptosis Pathway](/mechanisms/apoptosis-neurodegeneration), [CASP9 Protein](/proteins/casp9-protein), [BCL2 Family Proteins](/proteins/bcl2-family-proteins)
Background
The study of Apoptotic Protease Activating Factor 1 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
External Links
- [PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
- [Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
- [Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data
References
[Unknown, (n.d.)](https://pubmed.ncbi.nlm.nih.gov/26068362/)
[Unknown, (n.d.)](https://pubmed.ncbi.nlm.nih.gov/27453417/)
[Unknown, (n.d.)](https://pubmed.ncbi.nlm.nih.gov/28423280/)
[Unknown, (n.d.)](https://pubmed.ncbi.nlm.nih.gov/29753943/)
[Unknown, (n.d.)](https://pubmed.ncbi.nlm.nih.gov/30650961/)
[Unknown, (n.d.)](https://pubmed.ncbi.nlm.nih.gov/31059682/)
[Unknown, (n.d.)](https://pubmed.ncbi.nlm.nih.gov/32877961/)
[Unknown, (n.d.)](https://pubmed.ncbi.nlm.nih.gov/33220142/)